Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Auron to Present New Preclinical Data for AUTX-703 at 2024 ASH Meeting
-
Latest WSO2 API Management Products Help Enterprises to Manage AI APIs, Maximize Developer Productivity, and Future-Proof Their Deployments
-
FortisBC Inc. joins General Fusion's Market Development Advisory Committee to examine potential for fusion energy deployment
-
Ken Marks Joins Cynomi as Chief Revenue Officer
-
Seanergy Maritime Reports Third Quarter and Nine Months Financial Results for the Periods Ended September 30, 2024
-
Global-e to Announce Financial Results for the Third Quarter 2024 on November 20, 2024
-
Bybit Powered by SATOS Introduces Exclusive Referral Bonuses for Dutch Users
-
Blink to establish a £100 million Special Purpose Vehicle to Drive Electric Vehicle Charger Investments, Engaging Axxeltrova Capital as First Funding Partner
-
Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024 in One Oral Presentation and Three Poster Presentations
-
PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform
-
NeurAxis to Host Third Quarter 2024 Results and Business Update Call on Tuesday, November 12, 2024
-
FortisBC Inc. joins General Fusion's Market Development Advisory Committee to examine potential for fusion energy deployment
-
Kronos Bio to Present Data at the ASH Annual Meeting from p300 KAT Inhibition Program in Multiple Myeloma
-
Disc Medicine Announces Multiple Presentations Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting
-
Cartesian Therapeutics Announces Presentation at the Upcoming 66th ASH Annual Meeting
-
C4 Therapeutics to Present Data from the Ongoing Phase 1/2 Trial of Cemsidomide in Multiple Myeloma and Non-Hodgkin’s Lymphoma at the American Society of Hematology (ASH) Annual Meeting
-
Beam Therapeutics to Present Data Across Hematology Franchise, Including First Clinical Data for BEAM-101 in Sickle Cell Disease and ESCAPE Non-human Primate Data, at American Society of Hematology (A
-
Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
-
Pangea Launches Two New Advanced Materials
-
kama.ai Supports Community Circle’s OWL Project with Responsible AI for Sustainable Water Solutions
-
Pacific Eye Associates Selects Nextech
-
GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024
-
Kaiser Aluminum Corporation to Participate in Baird’s 2024 Global Industrial Conference
-
PRIDE Industries Achieves AS9100 Certification, Strengthening its Position in Aerospace and Defense Manufacturing
-
ImCheck to Present Updated Data from the EVICTION Trial at the 39th Annual Meeting of the Society for Immunotherapy of Cancer
-
John Snyder, Former BCD CEO and Travel Industry Leader, Joins Oversee’s Advisory Board
-
LPL Financial Welcomes GWC Financial Advisors to Linsco Channel
-
Terms for Nykredit's and Totalkredit's auctions - Totalkredit A/S
-
Spirit Blockchain Capital Strengthens its Ecosystem Position with Acquisition of Dogecoin Holdings
-
Itron Enhances Intelligent Connectivity Suite for Utilities with eSIM Technology
-
AITX Anticipates Renewed Government Focus on Enhanced Security Measures Regardless of Election Outcomes
-
Novo Nordisk A/S - share repurchase programme
-
Consolidated Water Sets Third Quarter 2024 Investor Conference Call for Friday, November 15, 2024 at 11:00 a.m. ET
-
Phunware Appoints Global Technology and AI Leader Rahul Mewawalla as Chairman of the Board
-
Concerned Shareholder of Altius Renewable Royalties Urges Shareholders to REJECT the Take-Private Offer by an Affiliate of Northampton Capital Partners, LLC
-
Inozyme Pharma Reports Third Quarter 2024 Financial Results and Provides Business Highlights
-
BIGG Digital Assets’ Blockchain Intelligence Group Launches QLUE Express, Significantly Increasing the Addressable Market for its Proprietary Technology
-
Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s “Preclinical Screening Platform for Pain” Program
-
Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer
-
SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite™
-
Veru Announces Meta-analysis of Body Composition Data from Older Patients with Obesity which Supports Potential for Enobosarm to Optimize Weight Loss at ObesityWeek
-
Atossa Therapeutics Appoints Claudia Lopez, DVM, MSc, as Vice President, Clinical Product Development
-
SIMPPLE Ltd. Comments on Plan to Regain Nasdaq Compliance
-
Complete Solar Announces Preliminary Q3’24 Results
-
Enovix Completes $100 Million Equity Offering
-
Vaccinex Reports Improved Immunity Correlating with Clinical Benefit of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual Meeting
-
Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer
-
Martinrea International Inc. to Announce Third Quarter Results on November 12, 2024
-
Jones Soda Sets Third Quarter 2024 Conference Call for Wednesday, November 13, 2024, at 4:30 p.m. ET
-
Gaxos to Participate in The AI Summit New York on December 11th to December 12th in New York City
